Insider trades
Andrew Combs, Chief Officer of Prelude Therapeutics PRLD, has filed 3 purchases and 0 sales on the open market. The latest trade was on 02/04.
Andrew Combs
Chief Chemistry Officer
- Company
- Prelude Therapeutics PRLD
- First filing
- 23/02/09
- Trades
- 7 trades
- Buys / sales
- 3 / 0
- 12-month net buying
- No record
- Last trade
- 02/04
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/03/25 | 25/03/27 | 100,000 sh | $0.69 | $69,000 | +26.3% | |
PRLD | Open-market buy | 24/12/20–24/12/23 | 24/12/26 | 63,075 sh2 trades | $1.36avg. | $85,736.25 | +20.1% |